0000899243-23-004791.txt : 20230213 0000899243-23-004791.hdr.sgml : 20230213 20230213173126 ACCESSION NUMBER: 0000899243-23-004791 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Riga Thomas J CENTRAL INDEX KEY: 0001726378 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 23620248 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2022-12-31 0 0 1 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001726378 Riga Thomas J 2 ATLANTIC AVENUE, 6TH FLOOR BOSTON MA 02110 1 1 0 0 CEO & President Common Stock, $0.001 par value 2022-02-14 4 A 0 239500 0.00 A 1213340 D Common Stock, $0.001 par value 14139 I By 401(k) plan The restricted stock award grant was approved by Spectrum Pharmaceuticals, Inc.'s board of directors on February 14, 2022 with an issuance date of January 14, 2022. One third of the amount of restricted shares shall vest on each of December 30, 2022, 2023 and 2024, respectively. /s/ Keith M. McGahan, Attorney-in-Fact for Thomas J. Riga 2023-02-13